Havana, Apr 3 (EFE) .- Cuba reported 1,029 new cases of covid-19 this Saturday and has been exceeding the barrier of 1,000 daily infections for four consecutive days, including the record of 1,077 reported the day before.
The country accumulates so far 78,382 infections and 431 deaths, two of them in the last 24 hours, according to the daily report of the Ministry of Public Health (Minsap).
Of the new positives, detected by processing 20,974 samples in the 23 Molecular Biology laboratories in the country, 1,019 are autochthonous and 10 are imported.
26,034 people remain admitted to the hospitals: 4,806 active cases -32 in critical condition and 49 serious-, 3,975 with suspicious symptoms and the rest under epidemiological surveillance.
Havana leads the highest records by notifying 570 new patients, followed by the western province of Matanzas (100) and the eastern province of Santiago de Cuba (80).
In the Cuban capital there is a night curfew and schools, restaurants, bars and beaches remain closed, among other restrictive measures.
The scarcity derived from the economic crisis forces people to go out into the streets and make long lines to buy food and other basic products, which makes it difficult to contain the transmission in this territory.
The country develops five of its own vaccines against the coronavirus, two of which – Sovereign 02 and Abdala – are in the third and final stage of clinical trials to evaluate their efficacy.
In parallel to these trials, the health authorities have launched “controlled intervention studies” in Havana and the eastern part of the island that foresee the massive administration of these two vaccine candidates, including 1.7 million people in the capital.
None of these drugs still have an authorization for emergency use or registration, something that the authorities hope to achieve around June.
Cuba has not acquired vaccines on the international market, nor is it part of the Covax Mechanism created under the auspices of the World Health Organization (WHO) to promote equitable access to immunization in low- and middle-income nations. EFE
(c) EFE Agency